Author

Inken Flörkemeier

University Hospital Schleswig-HolsteinORCID 0000-0001-5885-6352Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alvaro Quevedo-OlmosiD· 1 shared Christoph RogmansiD· 1 shared D. HolthausiD· 1 shared D. O. BauerschlagiD· 1 shared Ina Gursinski· 1 shared Jörg Paul WeimeriD· 1 shared Mandy MangleriD· 1 shared Marzieh EhsaniiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alvaro Quevedo-OlmosORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyFrontiers in OncologyPeer-reviewedSep 2, 2024

Inhibition of ADAM17 increases cytotoxic effect of cisplatin in cervical spheroids and organoids

D. Holthaus, Christoph Rogmans, Ina Gursinski…·Nina Hedemann

This study shows that inhibiting ADAM17 enhances cisplatin's cytotoxic effect in cervical cancer spheroids and organoids, suggesting ADAM17 as a potential target for overcoming chemoresistance.

8 citations

humanexperimental assay

𝕏 PostBluesky